Arete Wealth Advisors LLC Acquires Shares of 1,070 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Arete Wealth Advisors LLC acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 1,070 shares of the medical equipment provider's stock, valued at approximately $525,000.

Several other large investors also recently made changes to their positions in ISRG. State Street Corp lifted its holdings in shares of Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the last quarter. FMR LLC lifted its stake in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after buying an additional 838,793 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider's stock worth $3,677,194,000 after buying an additional 143,440 shares during the period. Fisher Asset Management LLC increased its position in shares of Intuitive Surgical by 1.8% in the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider's stock worth $2,349,441,000 after acquiring an additional 86,208 shares in the last quarter. Finally, Baillie Gifford & Co. increased its position in shares of Intuitive Surgical by 0.6% in the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider's stock worth $1,890,676,000 after acquiring an additional 24,183 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on ISRG shares. Evercore ISI reaffirmed a "cautious" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Piper Sandler reaffirmed an "overweight" rating and issued a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Morgan Stanley raised Intuitive Surgical from an "equal weight" rating to an "overweight" rating and upped their price target for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a research report on Tuesday, November 26th. Finally, Stifel Nicolaus lifted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $550.28.

Intuitive Surgical Stock Performance

Shares of ISRG traded down $5.14 during trading hours on Friday, hitting $539.58. 1,071,354 shares of the company were exchanged, compared to its average volume of 1,439,538. The company has a market cap of $192.19 billion, a PE ratio of 86.75, a PEG ratio of 5.35 and a beta of 1.38. The firm's 50 day moving average is $520.67 and its 200-day moving average is $477.52. Intuitive Surgical, Inc. has a 52 week low of $320.26 and a 52 week high of $556.23.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company's stock, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the company's stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares of the company's stock, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock worth $25,012,927 in the last quarter. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.